Corpus Intelligence IC Memo — COBB HOSPITAL AND MEDICAL CENTER 2026-04-26 04:04 UTC
IC Memo — COBB HOSPITAL AND MEDICAL CENTER
Investment Committee Memorandum | GA | 367 beds | Grade B | EBITDA uplift $66.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COBB HOSPITAL AND MEDICAL CENTER

CCN 110143 | COBB, GA | 367 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

COBB HOSPITAL AND MEDICAL CENTER is a 367-bed suburban community hospital in COBB, GA with $897.0M in net patient revenue and a 6.1% operating margin. The hospital serves a payer mix of 16.8% Medicare, 8.8% Medicaid, and 74.3% commercial.

Thesis: Platform Growth. Our ML models identify $66.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.1% to 13.4% (+736bps).

Net Revenue HCRIS$897.0M
Current EBITDA COMPUTED$54.6M
Operating Margin COMPUTED6.1%
Occupancy HCRIS79.8%
Revenue / Bed COMPUTED$2.4M
Net-to-Gross HCRIS18.3%
Distress Probability ML39.8%

2. Market Context & Competitive Position

165
GA Hospitals
-2.8%
State Median Margin
43
Comparable Hospitals

GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of 6.1% places it above the state median. Among 43 size-comparable peers (184-734 beds), the median margin is -2.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (184-734), prioritizing same-state peers. 43 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COBB HOSPITAL AND MEDICAL CENT (Target)GA367$897.0M6.1%
NORTHSIDE HOSPITALGA719$2.58B-7.9%
NORTHEAST GEORGIA MEDICAL CENTGA645$1.55B4.4%
KENNESTONE HOSPITALGA642$1.50B15.3%
EMORY UNIVERSITY HOSPITALGA639$1.42B5.4%
EMORY UNIVERSITY HOSPITAL MIDTGA548$1.37B-15.4%
PIEDMONT HOSPITAL INC.GA569$1.32B4.0%
GRADY MEMORIAL HOSPITALGA694$1.19B-39.6%
NORTHSIDE HOSPITAL - GWINNETTGA404$1.07B-2.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $66.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$18.8M+210bp18mo
Cost to Collect4.5%2.5%$17.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$17.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$10.9M+122bp9mo
Clean Claim Rate88.0%96.0%$574K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$18.8M
Cost to Collect
$17.9M
Denial Rate Reduction
$17.8M
A/R Days Reduction
$10.9M
Clean Claim Rate
$574K
Total EBITDA Uplift$66.0M
Current EBITDA$54.6M
+ RCM Uplift+$66.0M
Pro Forma EBITDA$120.6M
Current Margin6.1%
Pro Forma Margin13.4%
WC Released (1x)$34.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$84.0M$1.02B12.15x64.8%
Base (11x exit)10.0x11.0x$84.0M$1.15B13.69x68.8%
Bull Case9.0x11.0x$75.6M$1.39B18.46x79.2%
Bull (12x exit)9.0x12.0x$75.6M$1.54B20.43x82.8%
Bear Case11.0x10.0x$92.4M$662.9M7.18x48.3%
Bear (11x exit)11.0x11.0x$92.4M$759.2M8.22x52.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 43 hospitals with 184-734 beds
  • Same-state prioritization (n=44)
  • Comp margins: P25=-15.3% / P50=-2.5% / P75=4.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.